Literature DB >> 7400211

Inhibition of benzo(a)pyrene carcinogenesis in rats with vitamin C.

G Kallistratos, E Fasske.   

Abstract

The s.c. infection of 10 mg benzo(a)pyrene dissolved in 1 ml tricaprylin induced in Wistar rats local malignant tumors, such as fibrosarcoma, rhabdomyosarcoma, and polymorph cell sarcoma. The growth of the tumors was relatively rapid, reaching weights of 140-155 g before rats died 142-168 days after the administration of the carcinogen. On the contrary, under the same experimental conditions, high doses of Vitamin C about 525 mg/day/rat administered orally in drinking water (total amount of Vitamin C 55 g/rat corresponding to 40% of their body weight ) inhibited to a great extent the benzo(a)pyrene carcinogenesis. Only one slowly growing rhabdomyosarcoma (13 g of weight) was developed showing characteristic damage of malignant cells and partial replacement of the neoplastic area with granuloma tissue. The significance ov Vitamin C for cancer prevention and treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400211     DOI: 10.1007/bf00411283

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  9 in total

1.  [The significance of the cis-aconitic acid for the biological inactivation of the 3,4-benzopyrene cancerogenesis (author's transl)].

Authors:  G Kallistratos
Journal:  Experientia       Date:  1975-04-15

2.  Alcoholic cirrhosis; complicated by polycythemia vera and then myelogenous leukemia and tolerance of large doses of vitamin C.

Authors:  E GREER
Journal:  Med Times       Date:  1954-11

Review 3.  The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance.

Authors:  E Cameron; L Pauling
Journal:  Chem Biol Interact       Date:  1974-10       Impact factor: 5.192

4.  The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

Authors:  E Cameron; A Campbell
Journal:  Chem Biol Interact       Date:  1974-10       Impact factor: 5.192

5.  Ascorbic acid, cell proliferation, and cancer.

Authors:  E Cameron; D Rotman
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

Review 6.  Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases.

Authors:  E Cameron; L Pauling
Journal:  Oncology       Date:  1973       Impact factor: 2.935

7.  The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy.

Authors:  E Cameron; A Campbell; T Jack
Journal:  Chem Biol Interact       Date:  1975-11       Impact factor: 5.192

8.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  Prevention of 3,4-benzopyrene carcinogenesis in presence of putrescine.

Authors:  G Kallistratos; E Fasske
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.